This site is intended for Healthcare professionals only.

Cadila Healthcare gets EIR report from USFDA

Cadila Healthcare gets EIR report from USFDA

New Delhi: Drug firm Cadila Healthcare said it has received Establishment Inspection Report (EIR) for Baddi manufacturing plant from the US health regulator after successful inspection closure.

The company’s “manufacturing plant at Baddi, Himachal Pradesh, has successfully obtained the Establishment Inspection Report from the United States Food and Drug Administration (USFDA)”, Cadila Healthcare said in a BSE filing.

This will now pave the way for further approval of products from this site, it added. The company makes formulations at its Baddi manufacturing facility.

Establishment Inspection Report is given to an establishment after the completion of the inspection by the FDA.

0 comment(s) on Cadila Healthcare gets EIR report from USFDA

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted
    Source: PTI

    Featured Jobs

    View all medical jobs at ➤

    Opinion Polls

    Should Government Doctors be allowed to do Private Practice?